List of works - Federico Rotolo

A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses

scientific article

A simulation procedure based on copulas to generate clustered multi-state survival data.

scientific article

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach.

scientific article published on 5 September 2014

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

scientific article

Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models.

scientific article published on 10 March 2016

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

scientific article published on 15 June 2016

Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology.

scientific article published on 11 January 2018

First-line treatment in metastatic colorectal cancer: Important or crucial?

scientific article

French Intensive Care Society, International congress - Réanimation 2016

scientific article published in June 2016

Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces.

scientific article published on 15 November 2016

Incorporation of nested frailties into semiparametric multi-state models

scientific article published on 17 September 2015

Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials.

scientific article published on 16 November 2015

Quelles exigences pour qu'un biomarqueur puisse être un critère de substitution acceptable ?

scientific article published on 01 June 2016

Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

scientific article

Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice

scientific article

Testing the treatment effect on competing causes of death in oncology clinical trials

scientific article

biospear: an R package for biomarker selection in penalized Cox regression

scientific article published on 12 September 2017

surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials

scientific article published on 13 December 2017

List of works by Federico Rotolo

A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses

A simulation procedure based on copulas to generate clustered multi-state survival data.

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach.

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models.

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology.

First-line treatment in metastatic colorectal cancer: Important or crucial?

French Intensive Care Society, International congress - Réanimation 2016

Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces.

Incorporation of nested frailties into semiparametric multi-state models

Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials.

Quelles exigences pour qu'un biomarqueur puisse être un critère de substitution acceptable ?

Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice

Testing the treatment effect on competing causes of death in oncology clinical trials

biospear: an R package for biomarker selection in penalized Cox regression

surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials